• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Pamela M. McMahon, PhD


  • Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, Gazelle GS, Weinstein MC.Annual financial impact of well-differentiated thyroid cancer care in the United States.Cancer. 2014 May 1;120(9):1345-52.
  • de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammem├Ągi MC, Hazelton WD, Feuer EJ, McMahon PM.Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.Ann Intern Med. 2014 Mar 4;160(5):311-20.
  • Meza R, Ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, Hazelton WD, Plevritis SK.Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.Cancer. 2014 Feb 27.
  • Hayes JH, Barry MJ, McMahon PM.Observation versus initial treatment for prostate cancer.Ann Intern Med. 2013 Oct 15;159(8):574.
  • Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Lee PA, McMahon PM.Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.Ann Intern Med. 2013 Jun 18;158(12):853-60.
  • Tramontano AC, Cipriano LE, Kong CY, Shepard JA, Lanuti M, Gazelle GS, McMahon PM.Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.AJR Am J Roentgenol. 2013 May;200(5):1020-7.
  • Cott Chubiz JE, Lee JM, Gilmore ME, Kong CY, Lowry KP, Halpern EF, McMahon PM, Ryan PD, Gazelle GS.Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.Cancer. 2013 Mar 15;119(6):1266-76.
  • Rosenberg MA, Feuer EJ, Yu B, Sun J, Henley SJ, Shanks TG, Anderson CM, McMahon PM, Thun MJ, Burns DM.Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death.Risk Anal. 2012 Jul;32 Suppl 1:S25-38.
  • McMahon PM, Hazelton WD, Kimmel M, Clarke LD.Chapter 13: CISNET lung models: comparison of model assumptions and model structures.Risk Anal. 2012 Jul;32 Suppl 1:S166-78.
  • McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS.Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.Risk Anal. 2012 Jul;32 Suppl 1:S117-24.
  • Abujudeh HH, Kaewlai R, McMahon PM, Binder W, Novelline RA, Gazelle GS, Thrall JH.Abdominopelvic CT increases diagnostic certainty and guides management decisions: a prospective investigation of 584 patients in a large academic medical center.AJR Am J Roentgenol. 2011 Feb;196(2):238-43.
  • Cipriano LE, Romanus D, Earle CC, Neville BA, Halpern EF, Gazelle GS, McMahon PM.Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.Value Health. 2011 Jan;14(1):41-52.
  • Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, Bhatnagar V, Sweeney CJ, Stahl JE, McMahon PM.Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.JAMA. 2010 Dec 1;304(21):2373-80.
  • Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS.Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.Radiology. 2010 Mar;254(3):793-800.
  • Kong CY, McMahon PM, Gazelle GS.Calibration of disease simulation model using an engineering approach.Value Health. 2009 Jun;12(4):521-9.
  • McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS.Adopting helical CT screening for lung cancer : potential health consequences during a 15-year period.Cancer. 2008 Dec 15;113(12):3440-9.
  • McMahon PM,Gazelle SG.Response to "comentary: lung cancer screening--progress or peril.Oncologist. 2008 Jun;13(6):733.
  • McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS.Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study.Radiology. 2008 Jul;248(1):278-87.
  • Lee JM, Kopans DB, McMahon PM, Halpern EF, Ryan PD, Weinstein MC, Gazelle GS.Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis.Radiology. 2008 Mar;246(3):763-71.
  • McMahon PM, Christiani DC.Computed tomography screening for lung cancer.BMJ. 2007 Feb 10;334(7588):271.
  • Knudsen AB, McMahon PM, Gazelle GS.Use of modeling to evaluate the cost-effectiveness of cancer screening programs.J Clin Oncol. 2007 Jan 10;25(2):203-8. Review.
  • McMahon PM, Zaslavsky AM, Weinstein MC, Kuntz KM, Weeks JC, Gazelle GS.Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.Med Decis Making. 2006 Sep-Oct;26(5):497-511.
  • Gazelle GS, McMahon PM, Siebert U, Beinfeld MT.Cost-effectiveness analysis in the assessment of diagnostic imaging technologies.Radiology. 2005 May;235(2):361-70.
  • Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC.Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.Radiology. 2004 Dec;233(3):729-39.
  • McMahon PM, Araki SS, Sandberg EA, Neumann PJ, Gazelle GS.Cost-effectiveness of PET in the diagnosis of Alzheimer disease.Radiology. 2003 Aug;228(2):515-22.
  • Gazelle GS, Hunink MG, Kuntz KM, McMahon PM, Halpern EF, Beinfeld M, Lester JS, Tanabe KK, Weinstein MC.Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.Ann Surg. 2003 Apr;237(4):544-55.
  • McMahon PM, Gazelle GS.Colorectal cancer screening issues: a role for CT colonography?.Abdom Imaging. 2002 May-Jun;27(3):235-43.
  • Gleason S, Furie KL, Lev MH, O'Donnell J, McMahon PM, Beinfeld MT, Halpern E, Mullins M, Harris G, Koroshetz WJ, Gazelle GS.Potential influence of acute CT on inpatient costs in patients with ischemic stroke.Acad Radiol. 2001 Oct;8(10):955-64.
  • McMahon PM, Halpern EF, Fernandez-del Castillo C, Clark JW, Gazelle GS.Pancreatic cancer: cost-effectiveness of imaging technologies for assessing resectability.Radiology. 2001 Oct;221(1):93-106.
  • Bosch JL, Lester JS, McMahon PM, Beinfeld MT, Halpern EF, Kaufman JA, Brewster DC, Gazelle GS.Hospital costs for elective endovascular and surgical repairs of infrarenal abdominal aortic aneurysms.Radiology. 2001 Aug;220(2):492-7.
  • McMahon PM, Bosch JL, Gleason S, Halpern EF, Lester JS, Gazelle GS.Cost-effectiveness of colorectal cancer screening.Radiology. 2001 Apr;219(1):44-50.
  • McMahon PM, Gazelle GS.The case for colorectal cancer screening.Semin Roentgenol. 2000 Oct;35(4):325-32.
  • McMahon PM, Araki SS, Neumann PJ, Harris GJ, Gazelle GS.Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease.Radiology. 2000 Oct;217(1):58-68.
  • Gazelle GS, McMahon PM, Scholz FJ.Screening for colorectal cancer.Radiology. 2000 May;215(2):327-35.